ATI-450 Plus Methotrexate (MTX) Versus Placebo Plus MTX in Participants With Moderate to Severe Active Rheumatoid Arthritis (RA)

NCT05279417 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

251

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: ATI-450 50 mg oral tablet BID
DRUG: Placebo oral tablet
DRUG: Methotrexate
DRUG: ATI-450 20 mg oral tablet BID

Sponsor

Aclaris Therapeutics, Inc.